Corpus Intelligence IC Memo — HAYWOOD REGIONAL MEDICAL CENTER 2026-04-26 05:02 UTC
IC Memo — HAYWOOD REGIONAL MEDICAL CENTER
Investment Committee Memorandum | NC | 121 beds | Grade C | EBITDA uplift $10.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

HAYWOOD REGIONAL MEDICAL CENTER

CCN 340184 | HAYWOOD, NC | 121 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

HAYWOOD REGIONAL MEDICAL CENTER is a 121-bed suburban community hospital in HAYWOOD, NC with $148.2M in net patient revenue and a -2.6% operating margin. The hospital serves a payer mix of 31.2% Medicare, 4.1% Medicaid, and 64.7% commercial.

Thesis: Undervalued. Our ML models identify $10.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.6% to 4.8% (+736bps).

Net Revenue HCRIS$148.2M
Current EBITDA COMPUTED$-3.8M
Operating Margin COMPUTED-2.6%
Occupancy HCRIS43.5%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS21.3%
Distress Probability ML48.9%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
57
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -2.6% places it below the state median. Among 57 size-comparable peers (60-242 beds), the median margin is -1.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (60-242), prioritizing same-state peers. 57 hospitals in the comp set.

HospitalStateBedsRevenueMargin
HAYWOOD REGIONAL MEDICAL CENTE (Target)NC121$148.2M-2.6%
DUKE RALEIGH HOSPITALNC186$683.0M3.7%
CATAWBA VALLEY MEDICAL CENTERNC200$451.9M5.9%
MARGARET R. PARDEE MEMORIAL HONC160$341.3M-5.7%
JOHNSTON HEALTHNC179$331.7M9.6%
WAKE MED CARY HOSPITALNC189$318.1M-3.6%
ATRIUM HEALTH UNIONNC183$302.3M7.0%
S.E. REGL MEDICAL CENTERNC179$298.1M-25.3%
ATRIUM HEALTH UNIVERSITY CITYNC104$286.9M28.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$3.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$95K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$3.0M
Denial Rate Reduction
$2.9M
A/R Days Reduction
$1.8M
Clean Claim Rate
$95K
Total EBITDA Uplift$10.9M
Current EBITDA$-3.8M
+ RCM Uplift+$10.9M
Pro Forma EBITDA$7.1M
Current Margin-2.6%
Pro Forma Margin4.8%
WC Released (1x)$5.7M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-5.9M$83.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-5.9M$90.4M0.00x-100.0%
Bull Case9.0x11.0x$-5.3M$124.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.3M$134.2M0.00x-100.0%
Bear Case11.0x10.0x$-6.5M$31.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.5M$32.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 57 hospitals with 60-242 beds
  • Same-state prioritization (n=58)
  • Comp margins: P25=-8.3% / P50=-1.4% / P75=6.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.